November 20-22, 2019
Oklahoma City, OK
Hosted by Stephenson Cancer Center

About the Conference
The University of Oklahoma Health Sciences Center and the NCI-Designated Stephenson Cancer Center are proud to host the 2019 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference in conjunction with a one-day Hands-on Workshop in Nanotechnology from November 20-22, 2019 in Oklahoma City, Oklahoma, USA. 

The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside. A patient advocate will present special talk on the applications of nanomedicine for myeloma.

Topics discussed in the planned thematic sessions include Gene and Drug Delivery, Drug Discovery and Applications, Theranostics, Nanoimmuno-Oncology, Extracellular Vesicles, Genome Editing, and RNA and Protein Delivery. The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists. 

Students and fellows will have an opportunity to present their work and compete for four cash awards. A special session titled “Art of Science in Light of Nanomedicine” will allow participants to display their best research as a photo with a caption and compete for cash award.


Art of Science in Light of Nanomedicine Photo Competition

Photo Contest Sample 1

Display your best research as a photo with a caption and compete for cash awards!


Print on glossy, canvas, or any other material of your choice.

Size – 8×11 inches

Caption – any catchy phrase depicting the photo.


Submit here

Registration & Call for Abstracts

Registration for the 2019 conference will open on Aug. 1, 2019. Please check back for the registration link at that time. There is no cost to register for the conference, but you will need to register to attend the conference.

Register for the Conference

Our call for Abstracts open Aug. 1, 2019. Please include the following with your proposal submission:

  • Title
  • Authors Names and Affiliations
  • Abstract Limit: 300 Words Max
  • Presenting Author: Underline
  • Presenting Author: Email
  • Font: Times New Roman
  • Font Size: 12
  • Acknowledgement of Funding

Submit an abstract

Conference Location & Parking

The Samis Family Education Center inside The Children's Hospital at OU Medicine on the Oklahoma Health Center campus. 1200 Childrens Ave., Oklahoma City, OK 73104

Parking is available for out-of-town guests. Please use the Events Parking Lot at The Children's Hospital. If you are an employee of the OU Health Sciences Center, please use your normal parking lot. The Samis Education Center is located just a few blocks north of the Stephenson Cancer Center and the Embassy Suites Hotel.

About The Stephenson Cancer Center 

Stephenson Cancer Center at OU Medicine ranks in the Top 50 in the nation for cancer care in the 2019-2020 U.S. News & World Report rankings. As Oklahoma’s only National Cancer Institute-Designated Cancer Center, Stephenson Cancer Center is one of the nation’s elite centers, representing the top 2% of cancer centers in the country. It is the largest and most comprehensive oncology practice in the state, delivering patient-centered, multidisciplinary care for every type of cancer. As one of the nation’s leading research organizations, the Stephenson Cancer Center uses the latest innovations to fight and eliminate cancer, and is currently ranked No. 1 among all cancer centers in the nation for the number of patients participating in clinical trials sponsored by the NCI’s National Clinical Trials Network. For more information, visit stephensoncancercenter.org.

2019 OU Medicine